Atazanavir (Reyataz): News & Research
- Recent Changes to the Reyataz (Atazanavir Sulfate) Capsule Labeling (February 8, 2013)
From U.S. Food and Drug Administration
On TheBodyPRO.com
- New Public-Private Partnership Will Allow Brazil to Produce Patented Antiretroviral for National Treatment Program (December 7, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
 The 800-mg Darunavir Tablet Arrives, and Scoring the Top Protease Inhibitors (November 18, 2012)
From Journal Watch
On TheBodyPRO.com
- Reyataz and Kidney Stones (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
On TheBodyPRO.com
 HIV JournalView: September 2012 (October 15, 2012)
David Alain Wohl, M.D., explores recently published findings regarding access to HIV care in the U.S., the impact of pain on clinic no-shows, links between atazanavir and gall/kidney stones, anal sex and HIV among women, and the limits of echocardiography.
In HIV JournalView, from TheBodyPRO.com
- Maraviroc Plus Atazanavir/Ritonavir in a Nuke-Sparing Regimen in Treatment-Naive Patients (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- First Report: Atazanavir-Related Gallstones (Cholelithiasis) (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- AIDS 2012: Other Treatment Studies (August 1, 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Outcomes From Switches to Atazanavir/r in London (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
 SPARTAN: Two-Drug, NRTI-Sparing Strategies Continue to Disappoint (June 8, 2012)
From Journal Watch
On TheBodyPRO.com
- No Association Between Atazanavir and MI or Stroke in D:A:D Study (March/April 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Case Reports: Cushing's Syndrome With Atazanavir/Ritonavir (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Maraviroc Plus Atazanavir/r Without Nukes Versus Standard of Care: 48-Week Results (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Norvir-Boosted Reyataz Comparable in HIV-Positive Women Versus Men (July 25, 2011)
From AIDSmeds.com
- Once-Daily 150-mg Maraviroc Explored in People Taking Atazanavir/Ritonavir (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Atazanavir Levels Indicate Need for Higher Dose During Pregnancy (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Atazanavir in Pregnancy: 155 Cases in London Clinics (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Atazanavir Use During Pregnancy (March/April 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approves Reyataz Labeling Update for Pregnant Women (February 16, 2011)
From Test Positive Aware Network
- Reyataz (Atazanavir) Label Revised, Adding Dosing Recommendations for Pregnancy and Postpartum Period (February 4, 2011)
From U.S. Food and Drug Administration
- Study Suggests Genetic Tests Could Help Predict Side Effect Risk From Reyataz, Sustiva (January 3, 2011)
A new study published in the Jan. 15 issue of The Journal of Infectious Diseases suggests genetic testing might help predict whether a person will have side effects from some HIV drugs.
From AIDSmeds.com
|
Advertisement
|
Email
Glossary
